Liver Diseases  >>  filibuvir (PF-00868554)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
filibuvir (PF-00868554) / Pfizer
NCT00987337 / 2009-009214-40: Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Completed
2
288
US, Canada, Europe, RoW
Filibuvir, Placebo
Pfizer
Hepatitis, Hepatitis C
01/12
01/12

Download Options